BUENA, N.J.--(BUSINESS WIRE)--IGI, INC. (AMEX:IG) announced the grant of a US patent (# 7,205,006) for encapsulated Mahonia Aquifolium Extract, Extraction Process and Pharmaceutical composition containing the same. The patent has been jointly issued to IGI and Prime Pharmaceutical. Apollo Pharmaceutical holds the exclusive worldwide licensing rights for all potential commercial applications of Psorberine.
